0001144204-16-086941.txt : 20160309
0001144204-16-086941.hdr.sgml : 20160309
20160309165009
ACCESSION NUMBER: 0001144204-16-086941
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160307
FILED AS OF DATE: 20160309
DATE AS OF CHANGE: 20160309
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ReWalk Robotics Ltd.
CENTRAL INDEX KEY: 0001607962
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: KOCHAV YOKNEAM BUILDING, FLOOR 6
STREET 2: P.O. BOX 161
CITY: YOKNEAM ILIT
STATE: L3
ZIP: 20692
BUSINESS PHONE: 97249590123
MAIL ADDRESS:
STREET 1: KOCHAV YOKNEAM BUILDING, FLOOR 6
STREET 2: P.O. BOX 161
CITY: YOKNEAM ILIT
STATE: L3
ZIP: 20692
FORMER COMPANY:
FORMER CONFORMED NAME: Argo Medical Technologies Ltd.
DATE OF NAME CHANGE: 20140513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dykan Jeff
CENTRAL INDEX KEY: 0001661229
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36612
FILM NUMBER: 161495117
MAIL ADDRESS:
STREET 1: KOCHAV YOKNEAM BUILDING, FLOOR 6
STREET 2: P.O. BOX 161
CITY: YOKNEAM ILIT
STATE: L3
ZIP: 20692
4
1
v433887_4.xml
OWNERSHIP DOCUMENT
X0306
4
2016-03-07
0
0001607962
ReWalk Robotics Ltd.
RWLK
0001661229
Dykan Jeff
C/O REWALK ROBOTICS, LTD.
3 HATNUFA ST. P.O. BOX 161
YOKNEAM ILIT
L3
20692203
ISRAEL
1
0
1
0
Ordinary Shares, par value NIS 0.01 per share
2016-03-07
4
S
0
3002
8.33
D
1762100
I
By partnership
Ordinary Shares, par value NIS 0.01 per share
6022
I
ESOP
The disposed of securities consist of 3,002 Ordinary Shares sold by Vitalife Partners (Overseas) L.P. ("Vitalife Partners Overseas").
The Reporting Person filed Form 4 on March 7, 2016, to report the disposition of Ordinary Shares held by Vitalife Partners (Israel) L.P. ("Vitalife Partners Israel"). That filing inadvertently reported that Vitalife Partners Israel sold 994 Ordinary Shares on March 4, 2016, when the Ordinary Shares actually sold was 993. The number of shares reported in Column 5 of this Form 4 reflects the correct holdings as of the date of this report on Form 4.
The Reporting Person is a director of SCP Vitalife II GP, Ltd. ("SCP Vitalife GP"), which is the sole general partner of SCP Vitalife II Associates, L.P. ("SCP Vitalife Associates"). SCP Vitalife Associates is the sole general partner of each of SCP Vitalife Partners II, L.P. ("SCP Vitalife") and SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Israel"), the direct beneficial owner of the Ordinary Shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of the Shares held by SCP Vitalife and SCP Vitalife Israel, except to the extent of his pecuniary interest therein.
SCP Vitalife Associates, as the general partner of SCP Vitalife and SCP Vitalife Israel, may be deemed to beneficially own 1,619,574 Ordinary Shares, which consist of 1,214,076 and 405,498 Ordinary Shares held by SCP Vitalife and SCP Vitalife Israel, respectively. SCP Vitalife GP is the general partner of SCP Vitalife Associates and, as such, shares voting and dispositive power over, and may be deemed to beneficially own, the Ordinary Shares held by the foregoing entities. The Reporting Person shares voting and dispositive power over, and may be deemed to beneficially own 1,762,100 Ordinary Shares, which consist of the Ordinary Shares as set forth in footnote (4) to this Form 4.
Consists of 1,619,574 Ordinary Shares held by the foregoing entities due to the Reporting Person serving as a director of SCP Vitalife GP, as well as (i) 62,006 Ordinary Shares held by Vitalife Partners Overseas, (ii) 20,506 Ordinary Shares held by Vitalife Partners Israel, (iii) 20,733 Ordinary Shares held by Vitalife Partners (D.C.M) L.P. ("Vitalife Partners DCM", and together with Vitalife Partners Overseas and Vitalife Partners Israel, the "Vitalife I Entities") and (iv) 39,281 Ordinary Shares currently held by the Office of the Chief Scientist of the State of Israel ("OCS"), that the Vitalife I Entities have the right to acquire from the OCS, due to the Reporting Person serving as a director of Vitalife Life Sciences Ltd., the general partner of Vitalife Partners Management L.P., which is the general partner of each of the Vitalife I Entities.
Represents 6,022 ordinary shares issuable upon the vesting of restricted stock units ("RSUs") granted on December 15, 2014 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in 12 equal quarterly installments starting on the first anniversary of the date of grant, with 2,007 ordinary shares presently issued and outstanding.
/s/ Kevin Hershberger, as attorney-in-fact
2016-03-09